- Revenue 2024
- $53,346,165
- Expenses 2024
- $53,483,722
Program services were 86.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- G05
- Classification
- 1000
- Street
- 1818 MARKET ST STE 3000
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Other organizations at this address
2 other organizations in the IRS Business Master File list the same street address. matched by us
This address is a suite or unit (STE 3000). Organizations that share one are often clients of the same office-services firm, accountant or registered agent rather than related to each other.
We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.
-
COALITION OF CANCER COOPERATIVE GROUPS
EIN 23-2935628
-
ECOG RESEARCH AND EDUCATION FOUNDATION INC
EIN 39-1723095
Mission and programs · 2024
Mission
THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS.
-
FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER PATIENTS. THIS FEDERAL FUNDING AIDS ECOG- ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. IN ADDITION, THE FUNDS ARE USED TO PROMOTE COLLABORATION ACROSS A PROLIFIC SCIENTIFIC COMMUNITY AND TO CONTINUE THE STRONG ENGAGEMENT OF PATIENT ADVOCACY AT ALL LEVELS.
Expenses $39,297,578
-
PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH NCI PROTOCOL. ALL FUNCTIONS ARE PERFORMED IN COMPLIANCE WITH FEDERAL, STATE AND LOCAL LAWS, WITH AN OVERARCHING GOAL OF REACHING FULL ACCRUALS TO FURTHER ADVANCE THE RESEARCH AND MEDICINE AIMED AT IMPROVING OUTCOMES FOR CANCER PATIENTS.
Expenses $4,848,349 · Revenue $7,409,962
-
FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT SPECIFIC RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT THE PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
Expenses $467,523 · Revenue $537,585
-
OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
Expenses $1,361,345 · Revenue $1,838,970
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Daniel Barboriak MDDANIEL BARBORIAK MD
BOARD MEMBER
- Total calculated
- $0
-
Al Bowen Benson MDAL BOWEN BENSON MD
BOARD MEMBER
- Total calculated
- $0
-
Patrick Flynn MDPATRICK FLYNN MD
BOARD MEMBER
- Total calculated
- $0
-
Stanley M Hamilton MDSTANLEY M HAMILTON MD
BOARD MEMBER
- Total calculated
- $0
-
Barry A Siegel MDBARRY A SIEGEL MD
BOARD MEMBER
- Total calculated
- $0
-
Mitchell Schnall MD PhDMITCHELL SCHNALL MD PHD
SECRETARY/TR
- Total calculated
- $0
- Hours/week
- 4
-
Peter O'Dwyer MDPETER O'DWYER MD
PRESIDENT
- Total calculated
- $0
- Hours/week
- 15
-
Donna MarinucciDONNA MARINUCCI
EXECUTIVE DI
- Total calculated
- $318,111
- From this org
- $304,916
- From related orgs
- $0
- Other
- $13,195
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $304,916
- Bonus
- not reported
- Other
- not reported
- Deferred
- $11,842
- Nontaxable benefits
- $1,353
- Filer's total
- $318,111
-
Jean MacDonaldJEAN MACDONALD
DEPUTY EXEC
- Total calculated
- $308,223
- From this org
- $271,847
- From related orgs
- $0
- Other
- $36,376
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $271,847
- Bonus
- not reported
- Other
- not reported
- Deferred
- $9,973
- Nontaxable benefits
- $26,403
- Filer's total
- $308,223
-
Kenneth RockwellKENNETH ROCKWELL
DIR REGULATO
- Total calculated
- $261,387
- From this org
- $222,411
- From related orgs
- $0
- Other
- $38,976
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $222,411
- Bonus
- not reported
- Other
- not reported
- Deferred
- $8,498
- Nontaxable benefits
- $30,478
- Filer's total
- $261,387
-
Pamela CoglianoPAMELA COGLIANO
DIRECTOR OF
- Total calculated
- $232,941
- From this org
- $198,544
- From related orgs
- $0
- Other
- $34,397
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $198,544
- Bonus
- not reported
- Other
- not reported
- Deferred
- $7,768
- Nontaxable benefits
- $26,629
- Filer's total
- $232,941
-
Kerry HigginsKERRY HIGGINS
DIRECTOR DAT
- Total calculated
- $249,520
- From this org
- $214,110
- From related orgs
- $0
- Other
- $35,410
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $214,110
- Bonus
- not reported
- Other
- not reported
- Deferred
- $8,157
- Nontaxable benefits
- $27,253
- Filer's total
- $249,520
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $53,346,165
- Expenses
- $53,483,722
- Contributions
- $43,846,729
- Grants paid
- $0
-
2023
- Revenue
- $52,804,335
- Expenses
- $52,712,275
- Contributions
- $45,881,692
- Grants paid
- $0
-
2022
- Revenue
- $47,611,416
- Expenses
- $47,501,599
- Contributions
- $42,816,877
- Grants paid
- $0
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $49,270,427
- Expenses
- $48,907,395
- Assets (EOY)
- $11,624,125
-
2020 · 990
- Revenue
- $42,828,537
- Expenses
- $42,644,697
- Assets (EOY)
- $13,431,417
-
2019 · 990
- Revenue
- $33,841,613
- Expenses
- $33,773,586
- Assets (EOY)
- $10,263,240
-
2018 · 990
- Revenue
- $36,956,875
- Expenses
- $36,719,372
- Assets (EOY)
- $11,169,804
-
2017 · 990
- Revenue
- $38,423,144
- Expenses
- $36,819,125
- Assets (EOY)
- $14,924,577
-
2016 · 990
- Revenue
- $38,105,486
- Expenses
- $35,031,465
- Assets (EOY)
- $15,748,847
-
2015 · 990
- Revenue
- $19,266,828
- Expenses
- $19,145,189
- Assets (EOY)
- $7,504,517
-
2014 · 990
- Revenue
- $12,102,785
- Expenses
- $11,564,996
- Assets (EOY)
- $6,526,601
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.
Form 990-N e-Postcard, tax year 2013
- Tax period
- 1 January 2013 to 31 December 2013
- Principal officer
-
Robert L Comis MDROBERT L COMIS MD
- Mailing address
- 1818 MARKET STREET SUITE 1100PHILADELPHIA PA 19103
As filed, from the IRS e-Postcard file of 26 October 2026. The IRS publishes only each organization's most recent postcard, so earlier years are not shown. A 990-N carries no financial detail. The postcard also gives the principal officer's address, which is not shown here.
Grants made
No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.
Grants received
-
2024 CANCER RESEARCH
-
2023 CANCER RESEARCH
-
2022 CANCER RESEARCH
-
2023 MEDICAL RESEARCH
-
2022 MEDICAL RESEARCH
-
2024 MEDICAL RESEARCH
-
$43,000
2024 INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
-
2024 CLINICAL INVESTIGATOR LEADERSHIP AWARD
-
$22,000
2023 INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 29 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.